Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ic, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Inhaled GDC-6988 in Patients With Muco-obstructive Disease

NCT06603246 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT06603246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06603246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ic, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, and Activity of Inhaled GDC-6988 in Patients With Muco-obstructive Disease
Lead sponsor
Genentech, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
November 18, 2024
Completion date
November 15, 2027
Enrollment
128 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, non-cystic fibrosis bronchiectasis